Statistics for Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer
Total visits
| views | |
|---|---|
| Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer | 251 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| JCO.2017.72.4138.pdf | 239 |
| java.util.UUID:0f8ec68d-68e1-4d41-a096-41e778a66b3b | 46 |
| java.util.UUID:d35a99a5-012f-432e-95af-c9f0ac26e706 | 16 |
| java.util.UUID:3cd1f2b7-70ed-4fef-8941-0f84939fbc57 | 5 |
Top country views
| views | |
|---|---|
| United States | 190 |
| Germany | 15 |
| Sweden | 7 |
| China | 5 |
| Ukraine | 5 |
| Canada | 2 |
| United Kingdom | 1 |
| Greece | 1 |
| Iran | 1 |
| Malaysia | 1 |
| Russia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 55 |
| Fairfield | 25 |
| Houston | 16 |
| Kiez | 11 |
| White Plains | 10 |
| Ann Arbor | 7 |
| Jacksonville | 7 |
| Cambridge | 6 |
| Indianapolis | 6 |
| Stockholm | 6 |
| Kiev | 5 |
| Gunzenhausen | 4 |
| Ling | 4 |
| Seattle | 3 |
| Washington | 3 |
| Brooklyn | 2 |
| Lake Mary | 2 |
| Toronto | 2 |
| Beijing | 1 |
| Chestertown | 1 |
| Chicago | 1 |
| Monmouth Junction | 1 |
| Mountain View | 1 |
| Philadelphia | 1 |
| Péfki | 1 |
| Saint Petersburg | 1 |
| San Francisco | 1 |
| Scottsdale | 1 |
| Seremban | 1 |
| Tehran | 1 |